Life Science Company News

Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Read more ››
By: GlobeNewswire - 14 Jun 2024

Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants

Read more ››
By: GlobeNewswire - 14 Jun 2024

The Enterprise Court of Nivelles approves the BioSenic restructuring plan  

Read more ››
By: GlobeNewswire - 14 Jun 2024

Hyde Park Capital Advises One of the Largest Skilled Home Health Services Companies in Florida, Pinnacle Home Care, on its Strategic Partnership with HCS-Girling

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

Vaxart Announces $40 Million Underwritten Offering of Common Stock

Read more ››
By: GlobeNewswire - 14 Jun 2024

Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)

Read more ››
By: GlobeNewswire - 14 Jun 2024

The American Diabetes Association Kicks Off the 84th Scientific Sessions with Breakthrough Diabetes Research

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

The Portland Clinic closing downtown surgery center

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)

Read more ››
By: GlobeNewswire - 13 Jun 2024

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Read more ››
By: GlobeNewswire - 13 Jun 2024

Voyager Therapeutics to Present at Multiple Virtual Investor Conferences

Read more ››
By: GlobeNewswire - 13 Jun 2024

IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100

Read more ››
By: GlobeNewswire - 13 Jun 2024

Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Read more ››
By: GlobeNewswire - 13 Jun 2024

Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors

Read more ››
By: GlobeNewswire - 13 Jun 2024

Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Study (SOL-R) in wet AMD at Investor Day, Along with Positive 48-week Data from HELIOS NPDR Study

Read more ››
By: GlobeNewswire - 13 Jun 2024

Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors

Read more ››
By: GlobeNewswire - 13 Jun 2024

Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors

Read more ››
By: GlobeNewswire - 13 Jun 2024

Beyond Air® Appoints David Webster as Chief Commercial Officer

Read more ››
By: GlobeNewswire - 13 Jun 2024

QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs

Read more ››
By: GlobeNewswire - 13 Jun 2024
Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate